Simplicity Solutions LLC trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 19.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 41,937 shares of the conglomerate’s stock after selling 9,896 shares during the period. Simplicity Solutions LLC’s holdings in Danaher were worth $10,065,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of the business. Peregrine Capital Management LLC increased its holdings in shares of Danaher by 19.8% during the 2nd quarter. Peregrine Capital Management LLC now owns 5,479 shares of the conglomerate’s stock valued at $1,315,000 after purchasing an additional 904 shares in the last quarter. V Square Quantitative Management LLC increased its holdings in shares of Danaher by 288.9% during the 2nd quarter. V Square Quantitative Management LLC now owns 5,842 shares of the conglomerate’s stock valued at $1,402,000 after purchasing an additional 4,340 shares in the last quarter. Ballentine Partners LLC increased its holdings in shares of Danaher by 37.1% during the 2nd quarter. Ballentine Partners LLC now owns 18,370 shares of the conglomerate’s stock valued at $4,409,000 after purchasing an additional 4,971 shares in the last quarter. National Bank of Canada FI increased its holdings in shares of Danaher by 148.0% during the 2nd quarter. National Bank of Canada FI now owns 887,808 shares of the conglomerate’s stock valued at $210,256,000 after purchasing an additional 529,839 shares in the last quarter. Finally, Patten Group Inc. increased its holdings in shares of Danaher by 4.7% during the 2nd quarter. Patten Group Inc. now owns 5,547 shares of the conglomerate’s stock valued at $1,331,000 after purchasing an additional 247 shares in the last quarter. 76.71% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on DHR shares. Bank of America boosted their price target on shares of Danaher from $250.00 to $280.00 in a report on Wednesday, July 26th. StockNews.com started coverage on shares of Danaher in a report on Friday. They issued a “buy” rating for the company. Wells Fargo & Company cut their price target on shares of Danaher from $285.00 to $247.00 and set an “overweight” rating for the company in a report on Tuesday, October 3rd. Raymond James boosted their price target on shares of Danaher from $270.00 to $290.00 and gave the stock an “outperform” rating in a report on Wednesday, July 26th. Finally, Barclays boosted their price target on shares of Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a report on Tuesday, July 25th. Four research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $287.93.
Insider Buying and Selling at Danaher
In other Danaher news, EVP Joakim Weidemanis sold 22,439 shares of the company’s stock in a transaction dated Wednesday, July 26th. The shares were sold at an average price of $263.42, for a total value of $5,910,881.38. Following the transaction, the executive vice president now owns 88,689 shares of the company’s stock, valued at $23,362,456.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, EVP Joakim Weidemanis sold 22,439 shares of the stock in a transaction dated Wednesday, July 26th. The shares were sold at an average price of $263.42, for a total transaction of $5,910,881.38. Following the sale, the executive vice president now owns 88,689 shares of the company’s stock, valued at $23,362,456.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Teri List sold 3,490 shares of the stock in a transaction dated Wednesday, July 26th. The stock was sold at an average price of $263.30, for a total transaction of $918,917.00. Following the sale, the director now directly owns 17,494 shares in the company, valued at approximately $4,606,170.20. The disclosure for this sale can be found here. Insiders have sold 47,922 shares of company stock valued at $12,552,233 over the last 90 days. 11.10% of the stock is owned by insiders.
Danaher Trading Up 0.2 %
Shares of DHR stock traded up $0.36 on Friday, hitting $217.23. 2,696,299 shares of the stock traded hands, compared to its average volume of 2,882,431. The firm’s 50-day moving average price is $250.94 and its two-hundred day moving average price is $244.36. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.70 and a current ratio of 2.08. The stock has a market capitalization of $160.39 billion, a PE ratio of 25.50, a PEG ratio of 2.34 and a beta of 0.81. Danaher Co. has a twelve month low of $208.96 and a twelve month high of $281.54.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Tuesday, July 25th. The conglomerate reported $2.05 EPS for the quarter, beating analysts’ consensus estimates of $2.01 by $0.04. Danaher had a net margin of 20.95% and a return on equity of 15.03%. The company had revenue of $7.16 billion for the quarter, compared to analysts’ expectations of $7.12 billion. During the same quarter in the prior year, the company posted $2.76 earnings per share. Danaher’s revenue for the quarter was down 7.7% compared to the same quarter last year. As a group, analysts anticipate that Danaher Co. will post 8.82 EPS for the current year.
Danaher Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, October 12th will be given a $0.27 dividend. The ex-dividend date of this dividend is Wednesday, October 11th. This represents a $1.08 dividend on an annualized basis and a yield of 0.50%. Danaher’s payout ratio is currently 12.68%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.